DataMeds AI MEDS Ratios (2023-2026)

NASDAQ MEDS
$1.45 +0.02 (+1.40%)
At close: Aug 20, 2026 · 4:00 PM EDT
Ratios Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin (Quarter) -5.86%9.19%10.06%6.38%6.49%7.67%-470.23%10.91%
EBT Margin (Quarter) -1,289.46%-32.91%-34.90%-298.53%-85.64%-1,139.04%-1,667.19%-496.46%
EBIT Margin (Quarter) -1,286.52%-30.75%-30.20%-288.57%-70.60%-1,047.11%-1,517.50%-385.72%
EBITDA Margin (Quarter) -1,286.52%-30.75%-30.20%-288.57%-70.60%-1,047.11%-1,517.50%-385.72%
Operating Margin (Quarter) -1,286.52%-30.75%-30.20%-288.57%-70.60%-1,047.11%-1,517.50%-385.72%
Net Margin (Quarter) -1,289.46%-32.91%-34.90%-298.53%-85.64%-1,139.04%-1,667.19%-496.46%
FCF Margin (Quarter) 740.81%18.29%-21.14%-12.40%-26.69%-37.68%-376.70%-218.85%
Efficiency
Inventory Average (Quarter) 5.01M4.77M8.26M7.78M4.89M
Assets Average (Quarter) 48.48M56.14M53.50M41.62M30.29M
Invested Capital (Quarter) 0.10M11.93M17.71M13.18M12.21M10.89M15.17M19.21M
Asset Utilization Ratio (Quarter) 0.600.650.640.560.46
Leverage & Solvency
Interest Coverage Ratio (Quarter) -23.75-437.75-12.68-19.67-21.02-4.04-22.13-28.952.65
Debt Ratio (Quarter) 1.030.310.330.430.470.770.92
Times Interest Earned (Quarter) -23.75-437.75-12.68-19.67-21.02-4.04-22.13-28.952.65
Valuation
Enterprise Value (Quarter) -0.00M-1.03M-2.52M-0.42M-4.23M-0.04M-0.05M
Return Ratios
Return on Sales (Quarter) -0.13%0.00%0.00%-0.03%-0.01%-0.11%-0.17%-0.05%
Return on Capital Employed (Quarter) -1,655.82%-308.15%-347.50%-791.84%3,590.84%
Return on Assets (Quarter) -0.01%-0.01%-0.01%-0.02%-0.03%